Antioxidants

Código QR

Antioxidants

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	MDPI AG 2013
Materias:	pharmacodynamics Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/toc/2076-3921
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients
por: Amedeo De Nicolò, et al.
Publicado: (2021)

Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia
por: Kim YJ, et al.
Publicado: (2019)

Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
por: Carla Miranda, et al.
Publicado: (2021)

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
por: Andreas Port, et al.
Publicado: (2021)

The analgesic and anti-inflammatory effects of zukamu granules, a traditional Chinese medical formulation
por: Qiang Yin, et al.
Publicado: (2019)

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
por: Yi Tao, et al.
Publicado: (2021)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
por: Frost C, et al.
Publicado: (2018)

Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy
por: Soo-Min Jang, et al.
Publicado: (2021)

LaTeX tutorial for the standardization and automation of population analysis reports
por: Thomas Frank, et al.
Publicado: (2021)

A Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan
por: Yukihiro Hamada, et al.
Publicado: (2021)

Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts AG, et al.
Publicado: (2018)

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
por: Rambiritch V, et al.
Publicado: (2016)

Quantitative Analysis of the Efficacy of PARP Inhibitors as Maintenance Therapy in Recurrent Ovarian Cancer
por: Lili Gao, et al.
Publicado: (2021)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
por: Gordon D, et al.
Publicado: (2021)

The Potential of Dietary Antioxidants
por: Irene Dini
Publicado: (2021)

Editorial on Anticancer Antioxidants
por: Suzana Borovic Sunjic, et al.
Publicado: (2021)

Dietary Antioxidants and Brain Health: Focus on Cognitive and Affective Disorders
por: Justyna Godos, et al.
Publicado: (2021)

Editorial: NSAIDs Pharmacogenomics
por: José A. G. Agúndez, et al.
Publicado: (2021)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013)

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
por: Kreutz RP, et al.
Publicado: (2013)

Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
por: Li SY, et al.
Publicado: (2013)

Immunocytokines: a review of molecules in clinical development for cancer therapy
por: List T, et al.
Publicado: (2013)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven&reg;)
por: Bartosh NS, et al.
Publicado: (2013)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor DR
Publicado: (2013)

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
por: van Rossem K, et al.
Publicado: (2013)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager W
Publicado: (2013)

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
por: Kwong LM
Publicado: (2013)

Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review
por: Brennan JL, et al.
Publicado: (2013)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
por: Lozano R, et al.
Publicado: (2013)

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study
por: Wang X, et al.
Publicado: (2013)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
por: Portell CA, et al.
Publicado: (2013)

Effect of statin therapy on vaspin levels in type 2 diabetic patients
por: Al-Azzam SI, et al.
Publicado: (2013)

Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
por: Di Pierro F, et al.
Publicado: (2013)

Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation
por: Pickett A
Publicado: (2013)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine. [Corrigendum]
por: Nanda K, et al.
Publicado: (2013)

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
por: Decker BS, et al.
Publicado: (2013)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno K, et al.
Publicado: (2013)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander RN, et al.
Publicado: (2013)